However, data from the Multidomain Alzheimer’s Preventive Trial (MAPT) indicated that plasma NfL was associated with cognitive scores and executive function only in older adults (median age 75 years) with MCI but not in individuals without cognitive impairment [50]. This evidence concerns the gene NEFL and Cognitive impairment.